{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-139899","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.712644+00:00","generated_at":"2026-05-19T10:39:17.600935+00:00","sec_items":["1.01","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tempest Therapeutics raises ~$4.6M gross in registered direct offering of stock and prefunded warrants","bullets":["Issued 405,000 shares at $6.25 each and prefunded warrants for 334,000 shares at $6.249 each.","Net proceeds estimated at ~$4.1M after placement agent fees and expenses.","Proceeds to support strategic alternative process and working capital; cash runway into Q2 2026.","Placement agent H.C. Wainwright receives 6.0% cash fee on gross proceeds.","Prefunded warrants exercisable at $0.001 per share, with 4.99% beneficial ownership limitation (holder may elect up to 9.99%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-139899","json":"https://secwatch.observer/filing/0001193125-25-139899.json","markdown":"https://secwatch.observer/filing/0001193125-25-139899.md","text":"https://secwatch.observer/filing/0001193125-25-139899.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312525139899/0001193125-25-139899-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312525139899/d908664d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:39:17.600935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}